{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T18:37:13Z","timestamp":1792521433097,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,1,13]],"date-time":"2016-01-13T00:00:00Z","timestamp":1452643200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12887-016-0546-5","type":"journal-article","created":{"date-parts":[[2016,1,13]],"date-time":"2016-01-13T21:33:40Z","timestamp":1452720820000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Varicella vaccine without human serum albumin versus licensed varicella vaccine in children during the second year of life: a randomized, double-blind, non-inferiority trial"],"prefix":"10.1186","volume":"16","author":[{"given":"Roman","family":"Prymula","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Simko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Povey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Kulcsar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,1,13]]},"reference":[{"key":"546_CR1","unstructured":"Lopez A, Schmid S, Bialek S: VPD Surveillance Manual: Varicella [ http:\/\/www.cdc.gov\/vaccines\/pubs\/surv-manual\/chpt17-varicella.pdf ]. Accessed 21 May, 2014."},{"key":"546_CR2","unstructured":"Vaccines and Immunizations: Varicella [ http:\/\/www.cdc.gov\/vaccines\/pubs\/pinkbook\/varicella.html ]. Accessed 21 May, 2014."},{"key":"546_CR3","first-page":"1127","volume":"57","author":"M Shapiro","year":"2011","unstructured":"Shapiro M, Kvern B, Watson P, Guenther L, McElhaney J, McGeer A. Update on herpes zoster vaccination: a family practitioner\u2019s guide. Can Fam Physician. 2011;57:1127\u201331.","journal-title":"Can Fam Physician"},{"key":"546_CR4","first-page":"1","volume":"56","author":"M Marin","year":"2007","unstructured":"Marin M, G\u00fcris D, Chaves SS, Schmid S, Seward JF, Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention (CDC). Prevention of varicella: recommendations of advisory committee on immunization practices (ACIP). MMRV Recomm Rep. 2007;56:1\u201340.","journal-title":"MMRV Recomm Rep"},{"key":"546_CR5","doi-asserted-by":"publisher","first-page":"3097","DOI":"10.1016\/S0264-410X(01)00035-4","volume":"19","author":"C Aebi","year":"2001","unstructured":"Aebi C, Fischer K, Gorgievski M, Matter L, Muhlemann K. Age-specific seroprevalence to varicella-zoster virus: study in Swiss children and analysis of European data. Vaccine. 2001;19:3097\u2013103.","journal-title":"Vaccine"},{"key":"546_CR6","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1017\/S0950268801005398","volume":"126","author":"G Gabutti","year":"2001","unstructured":"Gabutti G, Penna C, Rossi M, Salmaso S, Rota MC, Bella A, et al. The seroepidemiology of varicella in Italy. Epidemiol Infect. 2001;126:433\u201340.","journal-title":"Epidemiol Infect"},{"key":"546_CR7","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1016\/S0264-410X(01)00459-5","volume":"20","author":"G Kanra","year":"2002","unstructured":"Kanra G, Tezcan S, Badur S, Turkish National Study Team. Varicella seroprevalence in a random sample of the Turkish population. Vaccine. 2002;20:1425\u20138.","journal-title":"Vaccine"},{"key":"546_CR8","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S1473-3099(03)00519-X","volume":"3","author":"HJ Schmitt","year":"2003","unstructured":"Schmitt HJ, Booy R, Weil-Olivier C, Van Damme P, Cohen R, Peltola H. Child vaccination policies in Europe: a report from the summits of independent european vaccination experts. Lancet Infect Dis. 2003;3:103\u20138.","journal-title":"Lancet Infect Dis"},{"key":"546_CR9","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1007\/s00431-002-1053-2","volume":"161","author":"N Thiry","year":"2002","unstructured":"Thiry N, Beutels P, Shkedy Z, Vranckx R, Vandermeulen C, Wielen MV, et al. The seroepidemiology of primary varicella-zoster virus infection in Flanders (Belgium). Eur J Pediatr. 2002;161:588\u201393.","journal-title":"Eur J Pediatr"},{"key":"546_CR10","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00431-007-0424-0","volume":"167","author":"N Sengupta","year":"2008","unstructured":"Sengupta N, Booy R, Schmitt HJ, Peltola H, Van-Damme P, Schumacher RF, et al. Varicella vaccination in Europe: are we ready for a universal childhood program? Eur J Pediatr. 2008;167:47\u201355.","journal-title":"Eur J Pediatr"},{"key":"546_CR11","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1097\/00006454-200208000-00013","volume":"21","author":"ML Ciofi Degli Atti","year":"2002","unstructured":"Ciofi Degli Atti ML, Salmaso S, Bella A, Arigliani R, Gangemi M, Chiamenti G, et al. Pediatric sentinel surveillance of vaccine-preventable diseases in Italy. Pediatr Infect Dis J. 2002;21:763\u20138.","journal-title":"Pediatr Infect Dis J"},{"key":"546_CR12","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2807\/esm.10.01.00511-en","volume":"10","author":"A Pinot De Moira","year":"2005","unstructured":"Pinot De Moira A, Nardone A, ESEN2 Group. Varicella Zoster Virus Vaccination Policies and Surveillance Strategies in Europe. Euro Surveill. 2005;10:43\u20134.","journal-title":"Euro Surveill"},{"key":"546_CR13","first-page":"783","volume-title":"Vaccines","author":"A Gershon","year":"2004","unstructured":"Gershon A, Takahashi M, Seward J. Varicella vaccine. In: Plotkin SA, Orenstein WA, editors. Vaccines. 4th ed. Philadelphia (PA): Saunders; 2004. p. 783\u2013825.","edition":"4"},{"key":"546_CR14","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1136\/adc.85.2.83","volume":"85","author":"SA Skull","year":"2001","unstructured":"Skull SA, Wang EE. Varicella vaccination: a critical review of the evidence. Arch Dis Child. 2001;85:83\u201390.","journal-title":"Arch Dis Child"},{"key":"546_CR15","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/S0140-6736(12)61461-5","volume":"383","author":"R Prymula","year":"2014","unstructured":"Prymula R, Bergsaker MR, Esposito S, Gothefors L, Man S, Snegova N, et al. Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine versus one dose of monovalent varicella vaccine: a multicentre, observer-blind, randomised, controlled trial. Lancet. 2014;383:1313\u201324.","journal-title":"Lancet"},{"key":"546_CR16","first-page":"241","volume":"73","author":"World Health Organization","year":"1998","unstructured":"World Health Organization. The WHO position paper on varicella vaccines. Wkly Epidemiol Rec. 1998;73:241\u20138.","journal-title":"Wkly Epidemiol Rec"},{"issue":"Suppl 2","key":"546_CR17","doi-asserted-by":"publisher","first-page":"S191","DOI":"10.1086\/522157","volume":"197","author":"KK Macartney","year":"2008","unstructured":"Macartney KK, Burgess MA. Varicella vaccination in Australia and New Zealand. J Infect Dis. 2008;197 Suppl 2:S191\u20135.","journal-title":"J Infect Dis"},{"key":"546_CR18","first-page":"1","volume":"30","author":"National Advisory Committee on Immunization","year":"2004","unstructured":"National Advisory Committee on Immunization. National Advisory Committee on Immunization (NACI) update on varicella. Can Commun Dis Rep. 2004;30:1\u201326.","journal-title":"Can Commun Dis Rep"},{"key":"546_CR19","unstructured":"Childhood immunization calendar, Greece [ http:\/\/vaccine-schedule.ecdc.europa.eu\/Pages\/Scheduler.aspx ]. Accessed 9 May, 2014."},{"key":"546_CR20","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1086\/522163","volume":"197","author":"C Sadzot-Delvaux","year":"2008","unstructured":"Sadzot-Delvaux C, Rentier B, Wutzler P, Asano Y, Suga S, Yoshikawa T, et al. Varicella vaccination in Japan, South Korea and Europe. J Infect Dis. 2008;197:185\u201390.","journal-title":"J Infect Dis"},{"key":"546_CR21","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1136\/adc.2007.126243","volume":"93","author":"J Quian","year":"2008","unstructured":"Quian J, Ruttimann R, Romero C, Dall\u2019orso P, Cerisola A, Breuer T, et al. Impact of universal varicella vaccination of one year-olds in Uruguay: 1997\u20132005. Arch Dis Child. 2008;93:845\u201350.","journal-title":"Arch Dis Child"},{"key":"546_CR22","unstructured":"WHO vaccine preventable disease monitoring system: Immunization schedules by antigen, selection centre [ http:\/\/apps.who.int\/immunization_monitoring\/globalsummary\/schedules ]. Accessed 9 May, 2014."},{"key":"546_CR23","first-page":"112","volume":"40","author":"SL Liao","year":"2007","unstructured":"Liao SL, Huang T, Huang YC, Jiang DD. Survey of the status of self-paid varicella vaccination among children one to six years of age in Taiwan. J Microbiol Immunol Infect. 2007;40:112\u20135.","journal-title":"J Microbiol Immunol Infect"},{"key":"546_CR24","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1086\/522146","volume":"197","author":"MA Reynolds","year":"2008","unstructured":"Reynolds MA, Watson BM, Plott-Adams KK, Jumaan AO, Galil K, Maupin TJ, et al. Epidemiology of varicella hospitalizations in the United States, 1995\u20132005. J Infect Dis. 2008;197:120\u20136.","journal-title":"J Infect Dis"},{"key":"546_CR25","doi-asserted-by":"publisher","first-page":"387","DOI":"10.2165\/0063030-200822060-00005","volume":"22","author":"HW Kreth","year":"2008","unstructured":"Kreth HW, Lee BW, Kosuwon P, Salazar J, Gloriani-Barzaga N, Bock HL, et al. Sixteen years of global experience with the first refrigerator-stable varicella vaccine (Varilrix). BioDrugs. 2008;22:387\u2013402.","journal-title":"BioDrugs"},{"key":"546_CR26","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1542\/peds.112.6.1394","volume":"112","author":"PA Offit","year":"2003","unstructured":"Offit PA, Jew RK. Addressing parents\u2019 concerns: do vaccines contain harmful preservatives, adjuvants, additives, or residuals? Pediatr. 2003;112:1394\u20137.","journal-title":"Pediatr"},{"key":"546_CR27","unstructured":"EMA: The European Agency for the Evaluation of Medicinal Products: Note for Guidance on Plasma-Derived Medicinal Products. 2001. [ http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2009\/09\/WC500003613.pdf ] Accessed 7 October, 2015."},{"issue":"23\u201324","key":"546_CR28","doi-asserted-by":"publisher","first-page":"2942","DOI":"10.1016\/S0264-410X(02)00245-1","volume":"20","author":"YL Lau","year":"2002","unstructured":"Lau YL, Vessey SJ, Chan IS, Lee TL, Huang LM, Lee CY, et al. A comparison of safety, tolerability and immunogenicity of Oka\/Merck varicella vaccine and VARILRIX\u2122 in healthy children. Vacc. 2002;20(23\u201324):2942\u20139.","journal-title":"Vacc"},{"issue":"8","key":"546_CR29","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1097\/INF.0b013e318170bb22","volume":"27","author":"V Schuster","year":"2008","unstructured":"Schuster V, Otto W, Maurer L, Tcherepnine P, Pfletschinger U, Kindler K, et al. Immunogenicity and Safety Assessments After One and Two Doses of a Refrigerator-Stable Tetravalent Measles-Mumps-Rubella-Varicella Vaccine in Healthy Children During the Second Year of Life. Pediatr Infect Dis J. 2008;27(8):724\u201330.","journal-title":"Pediatr Infect Dis J"},{"key":"546_CR30","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1093\/biomet\/26.4.404","volume":"26","author":"CJ Clopper","year":"1934","unstructured":"Clopper CJ, Pearson ES. The use of confidence or fiducial limits illustrated in the case of binomial. Biometrika. 1934;26:404\u201313.","journal-title":"Biometrika"},{"key":"546_CR31","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1002\/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I","volume":"17","author":"RG Newcombe","year":"1998","unstructured":"Newcombe RG. Interval estimation for the difference between independent proportions: Comparison of eleven methods. Statist Med. 1998;17:873\u201390.","journal-title":"Statist Med"},{"key":"546_CR32","unstructured":"EMEA\u2013CHMP. EMEA\u2013CHMP: Position Statement on Creutzfeldt\u2013Jakob Disease and Plasma-derived and Urine-derived Medicinal Products (2004). [ http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Position_statement\/2011\/06\/WC500108071.pdf ]. Accessed 9 May, 2014."},{"key":"546_CR33","first-page":"65","volume":"64","author":"AM Deedler","year":"1980","unstructured":"Deedler AM, Kornelis D. A comparison of the IFA and the ELISA for the demonstration of antibodies against Schistosome gut-associated polysaccharide antigens in Schistosomiasis. Parasite Res. 1980;64:65\u201375.","journal-title":"Parasite Res"},{"key":"546_CR34","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1292\/jvms.64.583","volume":"64","author":"Y Yahara","year":"2002","unstructured":"Yahara Y, Okhubo Y, Kariwa H, Takashima I. Evaluation of enzyme-linked immunosorbent assay (ELISA) and immunofluorescent antibody (IFA) test for the detection of porcine reproductive and respiratory syndrome virus (PRRSV) antibody in pigs from conventional farms. J Vet Med Science. 2002;64:583\u20138.","journal-title":"J Vet Med Science"},{"key":"546_CR35","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.vaccine.2008.10.064","volume":"27","author":"Y Gillet","year":"2009","unstructured":"Gillet Y, Steri GC, Behre U, Ars\u00e8ne JP, Lanse X, Helm K, et al. Immunogenicity and safety of measles-mumps-rubella-varicella (MMRV) vaccine followed by one dose of varicella vaccine in children aged 15 months\u20132 years or 2\u20136 years primed with measles-mumps-rubella (MMR) vaccine. Vaccine. 2009;27:446\u201353.","journal-title":"Vaccine."},{"key":"546_CR36","first-page":"991","volume":"40","author":"SR Hadinegoro","year":"2009","unstructured":"Hadinegoro SR, Hindra IS, Han HH, Gatchalian S, Bock HL. Reactogenicity and immunogenicity of a live-attenuated refrigerator-stable varicella vaccine (OKA strain) in healthy seronegative children age 10 months to 12 years. Southeast Asian J Trop Med Public Health. 2009;40:991.","journal-title":"Southeast Asian J Trop Med Public Health."}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-016-0546-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12887-016-0546-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-016-0546-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-016-0546-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T15:52:52Z","timestamp":1567525972000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-016-0546-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,13]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["546"],"URL":"https:\/\/doi.org\/10.1186\/s12887-016-0546-5","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,13]]},"article-number":"7"}}